Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer

Name: Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer
Published: 2016
License: Public Domain

Dan Zandberg · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

cisplatin radiation-therapy squamous-cell-carcinoma

head and neck squamous cell carcinoma, head and neck, locally advanced, squamous cell carcinoma, scchn, untreated, high risk, intermediate risk, radiation therapy, cisplatin, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer

Related documents